Structure-activity studies of 6-(tetrazolylalkyl)-substituted decahydroisoquinoline-3-carboxylic acid AMPA receptor antagonists .1. Effects of stereochemistry, chain length, and chain substitution

被引:43
作者
Ornstein, PL [1 ]
Arnold, MB [1 ]
Allen, NK [1 ]
Bleisch, T [1 ]
Borromeo, PS [1 ]
Lugar, CW [1 ]
Leander, JD [1 ]
Lodge, D [1 ]
Schoepp, DD [1 ]
机构
[1] LILLY RES CTR LTD, WINDLESHAM GU20 6PH, SURREY, ENGLAND
关键词
D O I
10.1021/jm950912p
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of 6-substituted decahydroisoquinoline-3-carboxylic acids were prepared as excitatory amino acid (EAA) receptor antagonists. These compounds are antagonists at the N-methyl-D-aspartate (NMDA) and 2-amino-3-(5-methyl-3-hydroxyisoxazol-4-yl)propanoic acid (AMPA) subclasses of ligand gated ion channel (ionotropic) EAA receptors. (3S,4aR,6R,8aR)-6-(2-(1H-tetrazol-5-yl)ethyl)-1,2,3,4,4a,5,6,7,8,8a-decahydroisoquiinoline-3-carboxylic acid (9) is a potent, selective and systemically active AMPA antagonist. Other analogs from this series, including (3S,4aR,6S,8aR)-6-((1H-tetrazol-5-yl)methyl)-1,2,3,4,4a,5,6,7,8,8a-decahydroisoquinoline-3-carboxylic acid (32) and (3S,4aR,6S,8aR)-6-(phosphonomethyl)-1,2,3,4,4a,5,6,7,8,8a-decahydroisoquinoline-3-carboxylic acid (61) are potent, selective, and systemically active NMDA antagonists. This and the subsequent publication look at the AMPA antagonist aspects of this SAR. Herein we report the effects of varying stereochemistry around the hydroisoquinoline ring; of tetrahydro- versus decahydroisoquinoline; of having the carboxylic acid at C-1 versus C-3; of varying the length of the carbon chain connecting a tetrazole to the bicyclic nucleus; and of holding the connecting chain constant at two atoms, the effect of heteroatom substitution in the position adjacent to the bicyclic nucleus and substitution with methyl or phenyl on the chain. Compounds were evaluated on rat cortical tissue for their ability to inhibit the binding of radioligands selective for AMPA ([H-3]AMPA), NMDA ([H-3]CGS 19755), and kainic acid ([H-3]- kainic acid) receptors and for their ability to inhibit depolarizations induced by AMPA (40 mu M), NMDA (40 mu M), and kainic acid (10 mu M). Our findings revealed that the optimal stereochemical array was the same for both NMDA (32 and 61) and AMPA (9) antagonists identified in this series and that the tetrahydroisoquinoline (25) and the C-1 carboxy (30) analogs of 9 are inactive. With a tetrazole in the distal acid position, an ethylene spacer (9) is optimal; substitution with oxygen or nitrogen on the chain in the position adjacent to the bicyclic nucleus significantly reduced activity, while substitution with a methyl or phenyl group on the chain was well tolerated.
引用
收藏
页码:2219 / 2231
页数:13
相关论文
共 51 条
[1]   THE AMPA ANTAGONIST, NBQX, PROTECTS AGAINST ISCHEMIA-INDUCED LOSS OF CEREBELLAR PURKINJE-CELLS [J].
BALCHEN, T ;
DIEMER, NH .
NEUROREPORT, 1992, 3 (09) :785-788
[2]   POTENT QUINOXALINE-SPACE PHOSPHONO ALPHA-AMINO-ACIDS OF THE AP-6-TYPE AS COMPETITIVE NMDA ANTAGONISTS - SYNTHESIS AND BIOLOGICAL EVALUATION [J].
BAUDY, RB ;
GREENBLATT, LP ;
JIRKOVSKY, IL ;
CONKLIN, M ;
RUSSO, RJ ;
BRAMLETT, DR ;
EMREY, TA ;
SIMMONDS, JT ;
KOWAL, DM ;
STEIN, RP ;
TASSE, RP .
JOURNAL OF MEDICINAL CHEMISTRY, 1993, 36 (03) :331-342
[3]   AMPA RECEPTOR ANTAGONISTS AND LOCAL CEREBRAL GLUCOSE-UTILIZATION IN THE RAT [J].
BROWNE, SE ;
MCCULLOCH, J .
BRAIN RESEARCH, 1994, 641 (01) :10-20
[4]   DELAYED AMPA RECEPTOR BLOCKADE REDUCES CEREBRAL INFARCTION INDUCED BY FOCAL ISCHEMIA [J].
BUCHAN, AM ;
XUE, D ;
HUANG, ZG ;
SMITH, KH ;
LESIUK, H .
NEUROREPORT, 1991, 2 (08) :473-476
[5]  
BUCHAN AM, 1993, STROKE S1, V24, P148
[6]   NEUROPROTECTIVE EFFECT OF THE AMPA RECEPTOR ANTAGONIST LY-293558 IN FOCAL CEREBRAL-ISCHEMIA IN THE CAT [J].
BULLOCK, R ;
GRAHAM, DI ;
SWANSON, S ;
MCCULLOCH, J .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 1994, 14 (03) :466-471
[7]   COMPETITIVE NMDA ANTAGONISTS THAT BASE THEIR ACTIVITY ON A UNIQUE CONFORMATIONAL EFFECT [J].
CLAESSON, A ;
SWAHN, BM ;
EDVINSSON, KM ;
MOLIN, H ;
SANDBERG, M .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1992, 2 (10) :1247-1250
[8]  
COLLINGRIDGE GL, 1989, PHARMACOL REV, V41, P143
[9]   EXCITATORY AMINO-ACID RECEPTORS - A GALLERY OF NEW TARGETS FOR PHARMACOLOGICAL INTERVENTION [J].
CUNNINGHAM, MD ;
FERKANY, JW ;
ENNA, SJ .
LIFE SCIENCES, 1994, 54 (03) :135-148
[10]   PROTECTION AGAINST ISCHEMIC HIPPOCAMPAL CA1 DAMAGE IN THE RAT WITH A NEW NON-NMDA ANTAGONIST, NBQX [J].
DIEMER, NH ;
JORGENSEN, MB ;
JOHANSEN, FF ;
SHEARDOWN, M ;
HONORE, T .
ACTA NEUROLOGICA SCANDINAVICA, 1992, 86 (01) :45-49